Trial Profile
A Phase 2 Study of Low-Dose Fractionated Radiation Therapy to the Whole Liver in Combination With Gemcitabine and Cisplatin in Locally Advanced Mass-Forming Intrahepatic Cholangiocarcinoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Mar 2019
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Cholangiocarcinoma; Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Oct 2016 Status changed from recruiting to discontinued.
- 10 Oct 2014 New trial record